Lyra Therapeutics, Inc.LYRAEarnings & Financial Report

Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus

Deep AnalysisCompare

Lyra Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing innovative, long-acting, locally delivered therapies for ear, nose, and throat (ENT) conditions. Its lead product candidates target chronic rhinosinusitis, addressing unmet medical needs for patients who do not get relief from standard treatments, with core operations based in the United States.